Literature DB >> 487646

The spleen is required for the suppression of experimental allergic encephalomyelitis by prostaglandin precursors.

J Mertin, A Stackpoole.   

Abstract

In this paper we report a study of the effects of splenectomy on the immunosuppressive action of essential fatty acids (EFA) which is thought to be mediated through prostaglandins (PG) produced in the spleen. Experimental allergic encephalomyelitis (EAE) was induced in normal, splenectomized and sham splenectomized Lewis rats. EFA were administered orally, the animals in the control groups being treated with liquid paraffin. Treatment with EFA significantly suppressed clinical disease in those animals in which EAE was induced by the inoculation of central nervous system material of guinea-pigs or by passive transfer by Con A-stimulated spleen cells. Splenectomy abrogated the suppressive effect of EFA. This observation, together with previous results showing the abrogation of EFA immunosuppression by an inhibitor of the biosynthesis of PG from EFA, led us to postulate a close relationship between EFA, PG and a splenic factor suppressing immunopathological mechanisms in EAE.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 487646      PMCID: PMC1537739     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  30 in total

1.  Transfer of allergic encephalomyelitis using splenectomized albino rats.

Authors:  P Y PATERSON; N C DIDAKOW
Journal:  Proc Soc Exp Biol Med       Date:  1961-12

2.  Evidence for suppressor cells in Lewis rats' experimental allergic encephalomyelitis.

Authors:  D H Adda; E Beraud; R Depieds
Journal:  Eur J Immunol       Date:  1977-09       Impact factor: 5.532

3.  Chronic relapsing experimental allergic encephalomyelitis: an experimental model of multiple sclerosis.

Authors:  H M Wiśniewski; A B Keith
Journal:  Ann Neurol       Date:  1977-02       Impact factor: 10.422

4.  Experimental allergic encephalomyelitis--migration of early T cells from the circulation into the central nervous system.

Authors:  U Traugott; S H Stone; C S Raine
Journal:  J Neurol Sci       Date:  1978-03       Impact factor: 3.181

5.  Experimental allergic encephalomyelitis: enhancement of cell-mediated transfer by concanavalin A.

Authors:  H S Panitch; D E McFarlin
Journal:  J Immunol       Date:  1977-09       Impact factor: 5.422

6.  Subpopulations of mouse T lymphocytes. II. Suppression of graft-vs.-host reactions by naturally proliferating splenic T cells.

Authors:  J W Moorhead
Journal:  Eur J Immunol       Date:  1978-03       Impact factor: 5.532

7.  Suppression of chronic allergic encephalomyelitis: relevance to multiple sclerosis.

Authors:  C S Raine; U Traugott; S H Stone
Journal:  Science       Date:  1978-08-04       Impact factor: 47.728

8.  Disposition and activity in experimental allergic encephalomyelitis of flumizole, a nonacidic, nonsteroidal, anti-inflammatory agent.

Authors:  H M McIlhenny; S Levine; E H Wiseman; R Sowinski
Journal:  Exp Neurol       Date:  1978-01-01       Impact factor: 5.330

9.  Suppression by essential fatty acids of experimental allergic encephalomyelitis is abolished by indomethacin.

Authors:  J Mertin; A Stackpoole
Journal:  Prostaglandins Med       Date:  1978-10

10.  Reduction by linoleic acid of the severity of experimental allergic encephalomyelitis in the guinea pig.

Authors:  C J Meade; J Mertin; J Sheena; R Hunt
Journal:  J Neurol Sci       Date:  1978-02       Impact factor: 3.181

View more
  5 in total

1.  Induction of immune responses in vivo with small numbers of veiled (dendritic) cells.

Authors:  S C Knight; J Mertin; A Stackpoole; J Clark
Journal:  Proc Natl Acad Sci U S A       Date:  1983-10       Impact factor: 11.205

2.  The protective effects of omega-6 fatty acids in experimental autoimmune encephalomyelitis (EAE) in relation to transforming growth factor-beta 1 (TGF-beta1) up-regulation and increased prostaglandin E2 (PGE2) production.

Authors:  L S Harbige; L Layward; M M Morris-Downes; D C Dumonde; S Amor
Journal:  Clin Exp Immunol       Date:  2000-12       Impact factor: 4.330

3.  Effect of indomethacin treatment upon actively-induced and transferred experimental allergic encephalomyelitis (EAE) in Lewis rats.

Authors:  H Ovadia; P Y Paterson
Journal:  Clin Exp Immunol       Date:  1982-08       Impact factor: 4.330

4.  Linoleic acid therapy in severe experimental allergic encephalomyelitis in the guinea-pig: suppression by continuous treatment.

Authors:  D Hughes; A B Keith; J Mertin; E A Caspary
Journal:  Clin Exp Immunol       Date:  1980-06       Impact factor: 4.330

5.  The effect of omega-3 fatty acids on central nervous system remyelination in fat-1 mice.

Authors:  Elise Siegert; Friedemann Paul; Michael Rothe; Karsten H Weylandt
Journal:  BMC Neurosci       Date:  2017-01-24       Impact factor: 3.288

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.